•  
  •  
  •  
  •  

2025-09-03 14:47:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  EIR

Stock Report

  • SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services
  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for API-III facility at Karakhadi
  • Zydus receives EIR for the API manufacturing facility at Ankleshwar
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • Zydus receives EIR for the Ambernath API manufacturing facility
  • India Glycols Limited receives EIR from USFDA for Dehradun Plant
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA
  • Lupin Receives EIR from U. S. FDA for its Somerset Manufacturing Facility
  • Aarti Drugs Ltd receives EIR from USFDA for Tarapur API facility
  • Gandhar Oil Refinery India Ltd receives EIR from USFDA classifying VAI
  • US FDA inspection at Alembic Pharmaceuticals Limited' Oral Solid Formulation Facility at Panelav
  • Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility
  • Wanbury receives EIR from USFDA for Patalganga facility
  • Strides Pharma Science Ltd gets EIR from USFDA on continued GMP status for the facility in Alathur, Chennai
  • Pinnacle Life Science Pvt Ltd receives EIR from USFDA for Baddi facility
  • Lupin receives EIR from U.S. FDA for its Dabhasa Facility

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024